119 related articles for article (PubMed ID: 8217787)
21. Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome.
Rønnov-Jessen D; Løvgreen Nielsen P; Horn T
Bone Marrow Transplant; 1991 Nov; 8(5):413-5. PubMed ID: 1768977
[TBL] [Abstract][Full Text] [Related]
22. Secondary leukaemia after autologous bone marrow transplantation.
Kumar L
Lancet; 1995 Apr; 345(8953):810. PubMed ID: 7898226
[No Abstract] [Full Text] [Related]
23. Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
Büchner T; Berdel WE; Schoch C; Haferlach T; Serve HL; Kienast J; Schnittger S; Kern W; Tchinda J; Reichle A; Lengfelder E; Staib P; Ludwig WD; Aul C; Eimermacher H; Balleisen L; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
J Clin Oncol; 2006 Jun; 24(16):2480-9. PubMed ID: 16735702
[TBL] [Abstract][Full Text] [Related]
24. Early myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloid leukemia.
Muroi K; Kawano C; Yokote T; Otsuki T; Kirito K; Komatsu N; Ozawa K
Leuk Lymphoma; 2002 Jul; 43(7):1493-6. PubMed ID: 12389635
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG).
De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():38-9. PubMed ID: 2697398
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG).
De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J
Br J Haematol; 1990 Feb; 74(2):151-5. PubMed ID: 2180469
[TBL] [Abstract][Full Text] [Related]
27. Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
Lonial S; Bomberger C; Waller EK
Br J Haematol; 2001 Apr; 113(1):224-30. PubMed ID: 11328305
[TBL] [Abstract][Full Text] [Related]
28. Listeria meningitis after bone marrow transplantation.
Long SG; Leyland MJ; Milligan DW
Bone Marrow Transplant; 1993 Nov; 12(5):537-9. PubMed ID: 8298566
[TBL] [Abstract][Full Text] [Related]
29. [Allogeneic bone marrow transplantation in adult patients with serious hematological diseases 1985-1992].
Brinch L; Evensen SA; Blomhoff JP; Albrechtsen D
Tidsskr Nor Laegeforen; 1993 Nov; 113(27):3351-3. PubMed ID: 8273060
[TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Gassmann W; Schmitz N; Löffler H; De Witte T
Semin Hematol; 1996 Jul; 33(3):196-205. PubMed ID: 8819230
[No Abstract] [Full Text] [Related]
31. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Löffler H; Schmitz N; Gassmann W
Hematol Oncol Clin North Am; 1992 Jun; 6(3):619-31. PubMed ID: 1613010
[TBL] [Abstract][Full Text] [Related]
32. Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis.
Flynn CM; Hirsch B; Defor T; Barker JN; Miller JS; Wagner JE; Blazar BR; Burns LJ; Macmillan ML; Arora M; Weisdorf D
Am J Hematol; 2007 Oct; 82(10):867-72. PubMed ID: 17616969
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
[TBL] [Abstract][Full Text] [Related]
34. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
[TBL] [Abstract][Full Text] [Related]
35. Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage.
Ohtsubo K; Takase K; Nagafuji K; Henzan H; Tanimoto T; Fukuda T; Miyamoto T; Inaba S; Harada M
Am J Hematol; 2004 Dec; 77(4):400-4. PubMed ID: 15558806
[TBL] [Abstract][Full Text] [Related]
36. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
Dirnhofer S; Went P; Tichelli A
Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
[TBL] [Abstract][Full Text] [Related]
38. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
[TBL] [Abstract][Full Text] [Related]
39. High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
Petti MC; Tafuri A; Latagliata R; Aloe Spiriti MA; Montefusco E; Mancini M; Meloni G; Petrucci MT; Spadea A; Redi R; Alimena G; Mandelli F
Ann Hematol; 2003 Aug; 82(8):476-480. PubMed ID: 12835916
[TBL] [Abstract][Full Text] [Related]
40. Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation.
Cho SJ; Lee SJ; Yoo ES; Ryu KH; Seoh JY; Hong KS; Koo H
Pediatr Int; 2006 Apr; 48(2):174-7. PubMed ID: 16635180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
